Alan Lombard

Author PubWeight™ 0.75^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Inhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancer.	Mol Cancer Ther	2016	0.75